0001179110-11-015315.txt : 20111117
0001179110-11-015315.hdr.sgml : 20111117
20111117162910
ACCESSION NUMBER: 0001179110-11-015315
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111115
FILED AS OF DATE: 20111117
DATE AS OF CHANGE: 20111117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EYLENBOSCH HILDE
CENTRAL INDEX KEY: 0001272540
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16789
FILM NUMBER: 111213317
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: C/O INVERNESS MEDICAL INNOVATIONS INC
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALERE INC.
CENTRAL INDEX KEY: 0001145460
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 043565120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7816473900
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC
DATE OF NAME CHANGE: 20010720
4
1
edgar.xml
FORM 4 -
X0304
4
2011-11-15
0
0001145460
ALERE INC.
ALR
0001272540
EYLENBOSCH HILDE
51 SAWYER ROAD, SUITE 200
WALTHAM
02453
0
1
0
0
Chief Commercial Officer
Common Stock
2011-11-15
4
M
0
17229
15.47
A
47365
D
Common Stock
2011-11-15
4
S
0
17229
26.024
D
30136
D
Common Stock
43143
I
Spouse
Common Stock
3248
D
Employee Stock Option (Right to Buy)
15.47
2011-11-15
4
M
0
17229
D
2011-11-30
Common Stock
17229
0
D
These options became exercisable in four equal annual installments beginning 11/30/2002.
This derivative security does not have a price.
This reporting person disclaims beneficial ownership of the reported securities.
These securities are jointly owned with the reporting person's spouse.
Represents the weighted average purchase price. Securities were sold through approximately 114 separate block trades executed on the Transaction Date at an average price of $26.024. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
The transactions reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options.
/s/ Jay McNamara, Attorney in Fact
2011-11-17